Patents by Inventor Clémence DISDIER

Clémence DISDIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181592
    Abstract: A compound of formula (I), for use in the treatment of non-traumatic acquired brain injury, in which M represents a NR1R2 group, an OR1 group or a SR1 group, A represents a NR4R5 group, an OR10 group or a hydrogen atom, R3 is a (C1-C6)alkyl group, a (C1-C6)cycloalkyl group, an aryl group, a —CH2-aryl group, a CH2-(C1-C6)cycloalkyl group or a —CH2-heteroaryl group, and its addition salts with pharmaceutically acceptable acids. A compound of formula (I) wherein R5 is a (C1-C8)alkyl group or a (C1-C6)cycloalkyl group, said alkyl and cycloalkyl group being substituted with one, two or three —OCORa group(s).
    Type: Application
    Filed: April 23, 2021
    Publication date: June 15, 2023
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, WOMEN & INFANTS HOSPITAL OF RHODE ISLAND, SCIENTIAM PHARMA
    Inventors: Aloïse MABONDZO, Anne-Cécile GUYOT, Alain PRUVOST, Narciso COSTA, Hervé GALONS, Nassima OUMATA, Barbara STONESTREET, Clémence DISDIER